090720-Mazanti-Odense-faciliteter-153.jpg
090720-Mazanti-Odense-faciliteter-153.jpg
Events
15/05/2025
Webinar

Webinar 
Pay Transparency

Webinar 
Pay Transparency

Læs mere
Mazanti_Interiør_kbh 0_low.jpg (1)
Mazanti_Interiør_kbh 0_low.jpg (1)
Cases
28/04/2025

Dom i sagen om Hirtshals Yard:
Ledelsen ikke ansvarlig
for kæntret flydedok

Dom i sagen om Hirtshals Yard:
Ledelsen ikke ansvarlig
for kæntret flydedok

Læs mere
stairs.jpg
stairs.jpg
Insights
22/04/2025

The Legal 500
Country Comparative Guide:
Mergers & Acquisitions Denmark

The Legal 500
Country Comparative Guide:
Mergers & Acquisitions Denmark

Læs mere
Intranet (29)
Intranet (29)
Firm News
26/03/2025

Mazanti-Andersen is Recognised
as a Top Tier Firm in the
2025 edition of The Legal 500

Mazanti-Andersen is Recognised
as a Top Tier Firm in the
2025 edition of The Legal 500

Læs mere
Alle |
Events |
Cases |
Insights |
Firm News
Mazanti Social Club (10).png
 Events
30/10/2024

Temperaturen på ejendomsmarkedet (Odense)

Læs mere
Q1080276_+Blå_Low.jpg (1)
 Cases
25/10/2024

Danish bioinformatics platform PipeBio acquired by US-based Benchling

Læs mere
stairs.jpg
 Cases
21/10/2024

Launch of PSV Hafnium – Denmark’s first dedicated early-stage deep tech fund

Læs mere
mazanti_andersen_010724_0272.jpg
 Cases
30/09/2024

Ascendis Pharma and Royalty Pharma enter into USD 150 million royalty funding agreement

Læs mere
Mazanti_Facade8_High.jpg
 Cases
30/09/2024

Ascendis Pharma completes public offering with gross proceeds of USD 345 million

Læs mere
Mazanti_Interiør_kbh 0_low.jpg (1)
 Cases
20/09/2024

Danish Cerebriu secures DKK 45 million to expand global access to AI-driven MRI technology

Læs mere
Mazanti Social Club (10).png
 Events
30/10/2024

Temperaturen på ejendomsmarkedet (Odense)

Læs mere
Q1080276_+Blå_Low.jpg (1)
 Cases
25/10/2024

Danish bioinformatics platform PipeBio acquired by US-based Benchling

Læs mere
stairs.jpg
 Cases
21/10/2024

Launch of PSV Hafnium – Denmark’s first dedicated early-stage deep tech fund

Læs mere
mazanti_andersen_010724_0272.jpg
 Cases
30/09/2024

Ascendis Pharma and Royalty Pharma enter into USD 150 million royalty funding agreement

Læs mere
Mazanti_Facade8_High.jpg
 Cases
30/09/2024

Ascendis Pharma completes public offering with gross proceeds of USD 345 million

Læs mere
Mazanti_Interiør_kbh 0_low.jpg (1)
 Cases
20/09/2024

Danish Cerebriu secures DKK 45 million to expand global access to AI-driven MRI technology

Læs mere